Fig. 5From: Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associationsIntersection of drug-target and target-adverse effect data (a). Precision (b) and Enrichment Factor (c) in drug-target identification comparing the 3D drug-target model leveraged with phenotypic data with the 3D drug-target model by itselfBack to article page